Minnesota takes aim at Sanofi, Novo, Lilly for insulin prices

Minnesota takes aim at Sanofi, Novo, Lilly for insulin prices

Source: 
Biopharma Dive
snippet: 

A lawsuit filed Tuesday claims that, rather than protect patient access, the companies jacked up insulin prices in order to offer greater rebates to PBMs.